top of page
2021_10_01_Epcon-6495.jpg

About us

“We believe we can improve health for all through
predictive analytics.”

EPCON is a company on a mission.

We believe technological innovation will improve health for all.

 

We are committed to be a driving force in this transformation. Using Artificial Intelligence (AI) we capture, combine and analyse data from a wide range of sources to measure disease burden and create predictive insights increasing the quality of health care. Our company runs on the enthusiasm and the skills of an amazing multidisciplinary team of machine learning architects, bioinformatics, medical and public health experts. Every one of us is committed to making a positive change in the world.

Our Team

Behind a great mission stands a great team.

 

Ours is an extremely qualified multidisciplinary group of machine learning architects, bioengineers, medical and public health experts working from Belgium, Portugal and South-Africa. At our core is a can-do attitude and a soft spot for never-been-done-before projects. Lifelong learning is key for us.  

EPCON_Turberculosis.jpg
Dr. Refiloe, CEO of Aquity Innovations

Dr. Refiloe Matji
CEO Aquity Innovations

a Public Health Physician based in South Africa. She is the Founder and CEO of a Non-Governmental Organization, AQUITY Innovations, and has been working in public health for over 20 years. Dr. Matji offers unparalleled expertise in programming, technical assistance, and capacity building for health programs, and serves in several international working groups working on TB and TB/HIV. Dr. Matji has also worked with BMGF, WHO, USAID, and other bodies on issues related to TB.

Our Advisory Board

Florian, Vice-president at Evotech

Dr. Florian von
Groote-Bidlingmaier
Executive Vice President, Evotec

Dr. Florian von Groote-Bidlingmaier is a specialist physician in internal medicine and pulmonology. Following his fellowship he worked on clinical trials with novel antituberculosis agents and combinations, with a special interest in the clinical development of treatments against drug-resistant tuberculosis. Since 2019, Dr. von Groote-Bidlingmaier has been Executive Vice President, Global Health at Evotec, an international drug discovery and development company, leading the global health programs out of Evotec's specialist infectious diseases site in Lyon, France.

Wilson Mok, advisory board member of Epcon

Dr. Wilson Mok
Global health expert

Dr. Wilson Mok is a global health expert who advises organizations focused on low- and middle-income countries. From 2013 until 2020, he worked for Gavi, the Vaccine Alliance, in various roles including as Head of Policy and coordinating the initial design of the COVAX Facility. Prior to Gavi, Dr. Mok was a strategy consultant at the Bill & Melinda Gates Foundation, focusing on HIV prevention, and a management consultant with McKinsey & Company, advising healthcare companies and public sector clients.

Keyboard and Mouse

Contact

Thanks for submitting!

bottom of page